98
Views
7
CrossRef citations to date
0
Altmetric
Original Research

A survey of patient preferences for a placebo orodispersible tablet

, &
Pages 201-206 | Published online: 20 Mar 2012

References

  • Nilausen DØ ZuikerRvan GervenJThe perception and pharmacokinetics of a 20-mg dose of escitalopram orodispersible tablets in a relative bioavailability study in healthy menClin Ther201133101492150221999886
  • HunterPCCrameriJAustinSWoodwardMCHughesAJResponse of parkinsonian swallowing dysfunction to dopaminergic stimulationJ Neurol Neurosurg Psychiatry19976355795839408096
  • NavarroVImproving medication compliance in patients with depression: Use of orodispersible tabletsAdv Ther2010271178579520878372
  • LlorcaPMDiscussion of prevalence and management of discomfort when swallowing pills: orodispersible tablets expand treatment options in patients with depressionTher Deliv20112561162222833978
  • AndersenOZweidorffOKHjeldeTRødlandEAProblems when swallowing tablets. A questionnaire study from general practiceTidsskr Nor Laegeforen19951158947949 Norwegian7709385
  • Márquez-ContrerasEGilVLópezJPharmacological compliance and acceptability of lansoprazole orally disintegrating tablets in primary careCurr Med Res Opin200824256957618194594
  • KohNSakamotoSChinoFImprovement in medication compliance and glycemic control with voglibose oral disintegrating tabletTohoku J Exp Med2008216324925718987459
  • ZigmondASSnaithRPThe hospital anxiety and depression scaleActa Psychiatr Scand1983673613706880820
  • WadeAGCrawfordGMBezlyakVWellbeing of patients prescribed long-term SSRIs by general practitioners in the UK [abstract]Eur Neuropsychopharmacol200818Suppl 4S333
  • ReganJSowmanRWalshIPrevalence of dysphagia in acute and community mental health settingsDysphagia20062129510116763936
  • RooseSPCompliance: the impact of adverse events and tolerability on the physician’s treatment decisionsEur Neuropsychopharmacol200313Suppl 3S859214550581
  • BenkertOSzegediAPhilippMMirtazapine orally disintegrating tablets versus venlafaxine extended release: a double-blind, randomized multicenter trial comparing the onset of antidepressant response in patients with major depressive disorderJ Clin Psychopharmacol200626757816415711